About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Back to clinical trial search

UNKNOWNNANCT03366909

Mindfulness Meditation and Cannabis Dependence : Therapy Effectiveness

Cannabis use can lead to addiction in about 5 to 10 % of users in France. Currently, behavioral interventions are the most dependable but effectiveness is still reduced. Mindfulness meditation has dem...

Lead sponsor: Central Hospital, Nancy, France•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Clareo turns complex medical information into clear understanding you can use.

Bring this clarity to your next appointment.

Keep all your medical notes and next steps in one place.

Contacts

Vincent Laprevote

CONTACT

03 83 92 84 40 Vincent.LAPREVOTE@cpn-laxou.com

Thomas Schwitzer

CONTACT

03 83 92 84 40 thomas.schwitzer@univ-lorraine.fr

Sponsors

Lead Sponsor

Central Hospital, Nancy, France

Age

18 - 55 years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•Aged from 18 to 55
•cannabis use: more than 7 joint a week or diagnostic of abuse/dependence at MINI (mini international neuropsychiatric interview)
•Recent use authenticated in urine
•patient voluntary to stop cannabis use
•patient with social security
•written consent for study

Exclusion Criteria

•alcohol dependence (AUDIT: alcohol use disorders test)
•other psychoactive substance abuse or dependence (DSM 4)
•Progressive psychiatric disorder (MINII) excepted anxious disorder)
•Current neurologic disorder
•Patient deficiency with difficulty or impossibility to understand informations
•protection of vulnerable adults as guardianship or judicial protection
•pregnant or breastfeeding woman
•vital emergency
•no social security
•participation in another interventional study
•current retinal disorder (ancillary study)
•chronic glaucoma (ancillary study)
•opthalmologic disease decreasing visual acuity (ancillary study)
•current ocular infection

Related studies

The Effect of Art-Based Nursing Intervention Helping to Develop Healthy Digital Habits on Digital Addiction, Cyberbullying and Self-Efficacy in Adolescents

NCT07123194 · Digital Addiction, Art Therapy, and more

Outcome Inference in the Sensory Preconditioning Task in Opioid-Use Disorder

NCT03745339 · Opioid-Related Disorders, Drug Addiction

RECRUITINGPhase 2

Accelerated dTMS Smoking Cessation

NCT07292883 · Tobacco Use Disorder, Addiction Nicotine

RECRUITINGPhase 1

The Impact of Product Formulation on the Pharmacokinetics and Pharmacodynamics of Cannabis Edibles

NCT05602649 · Cannabis Use

Phenotyping Patients With Alcohol and Cannabis Use Disorders Using the Addictions Neuroclinical Assessment

NCT05855668 · Alcohol Use Disorder, Cannabis Use Disorder

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: April 19, 2018Terms

Trial snapshot

StatusUNKNOWN

PhaseNA

Enrollment40

Start dateMay 2018

Last updatedApr 19, 2018

Condition

Addiction Cannabis Use Cannabis Dependence

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: April 19, 2018Data synced to Clareo: May 3, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions